EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 21 / No 10 (Octobre 2005) Med Sci (Paris), 21 10 (2005) 825-831 References
Free Access
Issue
Med Sci (Paris)
Volume 21, Number 10, Octobre 2005
Page(s) 825 - 831
Section M/S revues
DOI https://doi.org/10.1051/medsci/20052110825
Published online 15 October 2005
  1. Anitua E, Andia I, Ardanza B, et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004; 91 : 4–15. [Google Scholar]
  2. George JN. Platelets. Lancet 2000; 355 : 1531–9. [Google Scholar]
  3. Martinez MC, Kunzelmann C, Freyssinet JM. Remodelage de la membrane plasmique et stimulation cellulaire. Med Sci (Paris) 2004; 20 : 189–95. [Google Scholar]
  4. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004; 25 : 489–95. [Google Scholar]
  5. Fanslow WC, Srinivasan S, Paxton R, et al. Structural characteristics of CD40 ligand that determine biological function. Semin Immunol 1994; 6 : 267–78. [Google Scholar]
  6. Van Kooten C, Banchereau J. CD40-CD40 ligand. J Leuk Biol 2000; 67 : 2–17. [Google Scholar]
  7. Chan FK, Chun HJ, Zheng L, et al. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 2000; 288 : 2351–4. [Google Scholar]
  8. Van Kooten C, Banchereau J. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 1996; 61 : 1–77. [Google Scholar]
  9. Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper-igM syndrome. J Pediatr 1997; 131 : 47–54. [Google Scholar]
  10. Kuwana M, Nomura S, Fujimura K, et al. Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura. Blood 2004; 103 : 1229–36. [Google Scholar]
  11. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391 : 591–4. [Google Scholar]
  12. Aukrust P, Muller F, Ueland T, et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of t lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999; 100 : 614–20. [Google Scholar]
  13. Otterdal K, Pedersen TM, Solum NO. Release of soluble CD40 ligand after platelet activation: studies on the solubilization phase. Thromb Res 2004; 114 : 167–77. [Google Scholar]
  14. Furman MI, Krueger LA, Linden MD, et al. Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. J Am Coll Cardiol 2004; 43 : 2319–25. [Google Scholar]
  15. Solanilla A, Pasquet JM, Viallard JF, et al. Platelet-associated CD154 in immune thrombocytopenic purpura. Blood 2005; 105 : 215–8. [Google Scholar]
  16. Pietravalle F, Lecoanet-Henchoz S, Blasey H, et al. Human native soluble CD40l is a biologically active trimer, processed inside microsomes. J Biol Chem 1996; 271 : 5965–7. [Google Scholar]
  17. Graf D, Muller S, Korthauer U, et al. A soluble form of trap (CD40 ligand) is rapidly released after t cell activation. Eur J Immunol 1995; 25 : 1749–54. [Google Scholar]
  18. Karpusas M, Hsu YM, Wang JH, et al. 2A crystal structure of an extracellular fragment of human CD40 ligand. Structure 1995; 3 : 1031–9. [Google Scholar]
  19. Weber AA, Hermann A, Rauch BH, Schror K. Molecular identity of platelet CD40 ligand (CD40l). Thromb Haemost 2001; 86 : 718. [Google Scholar]
  20. Henn V, Steinbach S, Buchner K, et al. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001; 98 : 1047–54. [Google Scholar]
  21. Moss ML, Lambert MH. Shedding of membrane proteins by adam family proteases. Essays Biochem 2002; 38 : 141–53. [Google Scholar]
  22. Viallard JF, Solanilla A, Gauthier B, et al. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood 2002; 99 : 2612–4. [Google Scholar]
  23. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391 : 591–4. [Google Scholar]
  24. Andre P, Prasad KS, Denis CV, et al. CD40l stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002; 8 : 247–52. [Google Scholar]
  25. Lindmark E, Tenno T, Siegbahn A. Role of platelet p-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000; 20 : 2322–8. [Google Scholar]
  26. Slupsky JR, Kalbas M, Willuweit A, et al. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 1998; 80 : 1008–14. [Google Scholar]
  27. Schwabe RF, Schnabl B, Kweon YO, Brenner DA. CD40 activates nf-kappa B and c-jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells. J Immunol 2001; 166 : 6812–9. [Google Scholar]
  28. Tanaka T, Kuroiwa T, Ikeuchi H, et al. Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein-1 via the CD40/CD40 ligand pathway and may amplify glomerular injury. J Am Soc Nephrol 2002; 13 : 2488–96. [Google Scholar]
  29. Lei XF, Ohkawara Y, Stampfli MR, et al. Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice. J Clin Invest 1998; 101 : 1342–53. [Google Scholar]
  30. May AE, Kalsch T, Massberg S, et al. Engagement of glycoprotein iib/iiia (alpha[iib]beta3) on platelets upregulates CD40l and triggers CD40l-dependent matrix degradation by endothelial cells. Circulation 2002; 106 : 2111–7. [Google Scholar]
  31. Czapiga M, Kirk AD, Lekstrom-Himes J. Platelets deliver costimulatory signals to antigen-presenting cells: a potential bridge between injury and immune activation. Exp Hematol 2004; 32 : 135–9. [Google Scholar]
  32. Elzey BD, Tian J, Jensen RJ, et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 2003; 19 : 9–19. [Google Scholar]
  33. Prasad KS, Andre P, Yan Y, Phillips DR. The platelet CD40l/gp IIb-IIIa axis in atherothrombotic disease. Curr Opin Hematol 2003; 10 : 356–61. [Google Scholar]
  34. Buchner K, Henn V, Grafe M, et al. CD40 ligand is selectively expressed on CD4+ t cells and platelets: implications for CD40-CD40l signalling in atherosclerosis. J Pathol 2003; 201 : 288–95. [Google Scholar]
  35. Mach F, Schonbeck U, Sukhova GK, et al. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998; 394 : 200–3. [Google Scholar]
  36. Lutgens E, Gorelik L, Daemen MJ, et al. Requirement for CD154 in the progression of atherosclerosis. Nat Med 1999; 5 : 1313–6. [Google Scholar]
  37. Reul RM, Fang JC, Denton MD, et al. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection. Transplantation 1997; 64 : 1765–74. [Google Scholar]
  38. Kirk AD, Harlan DM, Armstrong NN, et al. Ctla4-ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997; 94 : 8789–94. [Google Scholar]
  39. Tamada K, Tamura H, Flies D, et al. Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease. J Clin Invest 2002; 109 : 549–57. [Google Scholar]
  40. Kalled SL, Cutler AH, Datta SK, Thomas DW. Anti-CD40 ligand antibody treatment of snf1 mice with established nephritis: preservation of kidney function. J Immunol 1998; 160 : 2158–65. [Google Scholar]
  41. Kairaitis L, Wang Y, Zheng L, et al. Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease. Kidney Int 2003; 64 : 1265–72. [Google Scholar]
  42. Ruth AJ, Kitching AR, Semple TJ, et al. Intrinsic renal cell expression of CD40 directs th1 effectors inducing experimental crescentic glomerulonephritis. J Am Soc Nephrol 2003; 14 : 2813–22. [Google Scholar]
  43. Yellin MJ, D’Agati V, Parkinson G, et al. Immunohistologic analysis of renal CD40 and CD40l expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum 1997; 40 : 124–34. [Google Scholar]
  44. Delmas Y, Viallard JF, Solanilla A, et al. Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154 dependent induction of CD40. Kidney Int 2005 (sous presse). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.